SCHEMBL4695073

SCHEMBL4695073

Nc1cccnc1.Nc1csc2cnccc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K7 O43318 5/20 0.42
TAB1 Q15750 5/20 0.42
DYRK1B Q9Y463 3/20 0.40
DYRK1A Q13627 2/20 0.39
LMNA P02545 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
AXL P30530 2/20 0.38
MEN1 O00255 1/20 0.38
PSIP1 O75475 1/20 0.38
MKNK1 Q9BUB5 1/20 0.38
MKNK2 Q9HBH9 1/20 0.38
CYP2A6 P11509 1/20 0.36
EP300 Q09472 1/20 0.34
KAT2B Q92831 1/20 0.34
KAT8 Q9H7Z6 1/20 0.34
GRM5 P41594 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30098534 0.88 CYP2A6 (0.43) MAP3K7TAB1LMNACYP1A2CYP3A4
SCHEMBL619829 0.88 CYP2A6 (0.43) MAP3K7TAB1LMNACYP1A2CYP3A4
SCHEMBL19628 0.74
SCHEMBL29455057 0.74
SCHEMBL31167180 0.73 CYP2A6 (0.56) DYRK1ALMNACYP1A2CYP3A4CYP2D6
SCHEMBL1006461 0.73 CYP2A6 (0.56) DYRK1ALMNACYP1A2CYP3A4CYP2D6
Hydrochloric Acid SCHEMBL2867683 0.72
Hydrochloric Acid SCHEMBL3365191 0.72
Bromide SCHEMBL30665091 0.72
Ammonia Solution, Strong SCHEMBL15387433 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931681-A1 SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS Glenmark Pharmaceuticals S.A. (CH) 2008-06-18 EP disclosed
WO-2007042906-A1 SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS S.A. (US) 2007-04-19 WO disclosed